CN103044576B - Method for improving stability of heparin sodium - Google Patents

Method for improving stability of heparin sodium Download PDF

Info

Publication number
CN103044576B
CN103044576B CN201210549739.9A CN201210549739A CN103044576B CN 103044576 B CN103044576 B CN 103044576B CN 201210549739 A CN201210549739 A CN 201210549739A CN 103044576 B CN103044576 B CN 103044576B
Authority
CN
China
Prior art keywords
heparin sodium
stability
reductive agent
product
feed liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210549739.9A
Other languages
Chinese (zh)
Other versions
CN103044576A (en
Inventor
刘乃山
夏衬来
迟培升
陆玉梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Jiulong biological medicine group Co., Ltd.
Original Assignee
QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd filed Critical QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Priority to CN201210549739.9A priority Critical patent/CN103044576B/en
Publication of CN103044576A publication Critical patent/CN103044576A/en
Application granted granted Critical
Publication of CN103044576B publication Critical patent/CN103044576B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a technical method for improving stability of heparin sodium. At present, a hydrogen peroxide oxidizing method is generally used for decoloring in a heparin sodium refining process; the prepared heparin sodium product contains residual peroxy ions (O22-); the stability of the product is affected in the heparin sodium storage process; and the biological value of the product is reduced. The method for improving the stability of the heparin sodium, provided by the invention, has the advantages as follows: through the adoption of a low temperature reduction method, residual oxygen ions generated in the refining process are removed and the product stability is improved.

Description

A kind of method improving stability of heparin sodium
Technical field
The present invention relates to a kind of raising stability of heparin sodium method, particularly a kind of heparin sodium production process.
Background technology
Heparin sodium is a kind of clinical conventional anticoagulation medicine, the mucopolysaccharide material mainly extracted from pig intestinal mucosa, has anticoagulation and prevent thrombotic effect significantly.The emerging in large numbers of low molecular sodium heparin product in recent years, makes the application of heparin sodium more and more extensive.Current heparin sodium industry is generally applied hydrogen peroxide oxidation process and is refined, and this technique comparatively potassium permanganate oxidation has sent out plurality of advantages, and technique is simple, and oxidation efficiency is high.But be also faced with the residue problem of peroxide radical ion simultaneously, bring challenges to the stability of heparin sodium.
Summary of the invention
Object of the present invention provides a kind of reductive agent to remove the method for residual oxygen radical ion in refining heparin sodium, overcomes the stability problem that hydrogen peroxide oxidation method for refining brings.
Object of the present invention reaches by the following technical programs, is realized successively by following step.
1, the heparin sodium refining through hydrogen peroxide is dropped in retort, dissolve in the ratio purified water of 1: 10 (w/w);
2, be cooled to 10-15 DEG C, adjust pH=9.0-10.0, add reductive agent A or reductive agent B in the ratio of 3-5%, insulation leaves standstill 10-12 hour;
3, feed liquid is filtered;
4, by the feed liquid after filtration, regulate pH=5.0-5.5, add sodium-chlor by 2-4% (w/v), adding 95% ethanol to alcohol concn is afterwards 38-45%, leaves standstill 10-12 hour, throw out dehydration post-drying.
The beneficial effect of the technical program is: the stability of heparin sodium product can be evaluated by accelerated test and long-term stable experiment data.The inventive method product through 6 months accelerated tests (temperature 40 ± 2 DEG C, relative humidity 75 ± 5%), titer of heparin sodium reduction≤2U/mg; Through 2 years long-term stable experiments, titer of heparin sodium reduction≤3U/mg.Without the obtained product of the traditional method of reduction through 6 months accelerated tests (temperature 40 ± 2 DEG C, relative humidity 75 ± 5%), titer of heparin sodium reduction >=6U/mg; Through 2 years long-term stable experiments, titer of heparin sodium reduction >=10U/mg, contrast was as following table.
The first, in the technical program, adding the temperature before reductive agent must be down to 10-15 DEG C, reflection mild condition.
The second, in the technical program, reductive agent A is V-Brite B, after diluting with gac or talcum powder, reduction reaction gentleness can be made to carry out.
3rd, in the technical program, reductive agent B is Sulfothiorine, after diluting with gac or talcum powder, reduction reaction gentleness can be made to carry out.
Embodiment
Following instance describes the present invention in detail:
1, by the heparin sodium 50Kg through hydrogen peroxide oxide purification, join in retort, add 500Kg purified water and fully dissolve.
2, be cooled to 15 DEG C, regulate pH=9.5, add reductive agent A22g (11g V-Brite B fully mixes with 11g gac), after stirring, stand at low temperature 10-12 hour.
3, feed liquid filter press device is filtered (millipore filtration aperture is 0.8 μm).
4, by the feed adjustment pH=5.0 after filtering, adding 16.5Kg sodium-chlor, is 40% with 95% alcohol settling to alcohol concn afterwards, leaves standstill 10 hours, and post-drying of dewatering, must have good stability heparin sodium.

Claims (1)

1. improve a method for stability of heparin sodium, it is characterized in that:
(1) heparin sodium refining through hydrogen peroxide is dropped in retort, dissolve by the mass ratio purified water of 1: 10;
(2) be cooled to 10-15 DEG C, adjust pH=9.0-10.0, add reductive agent A or reductive agent B in the ratio of 3-5%, insulation leaves standstill 10-12 hour;
(3) feed liquid is filtered;
(4) by the feed liquid after filtration, regulate pH=5.0-5.5, add sodium-chlor by 2-4% (w/v), adding 95% ethanol to alcohol concn is afterwards 38-45%, leaves standstill 10-12 hour, throw out dehydration post-drying;
Reductive agent A is V-Brite B and gac or V-Brite B and talcous mixture;
Reductive agent B is Sulfothiorine and gac or Sulfothiorine and talcous mixture;
Feed liquid is filtered into filters with filter press device, millipore filtration aperture≤0.8 μm.
CN201210549739.9A 2012-12-07 2012-12-07 Method for improving stability of heparin sodium Active CN103044576B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210549739.9A CN103044576B (en) 2012-12-07 2012-12-07 Method for improving stability of heparin sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210549739.9A CN103044576B (en) 2012-12-07 2012-12-07 Method for improving stability of heparin sodium

Publications (2)

Publication Number Publication Date
CN103044576A CN103044576A (en) 2013-04-17
CN103044576B true CN103044576B (en) 2015-07-15

Family

ID=48057457

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210549739.9A Active CN103044576B (en) 2012-12-07 2012-12-07 Method for improving stability of heparin sodium

Country Status (1)

Country Link
CN (1) CN103044576B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114276473A (en) * 2020-09-27 2022-04-05 上海帕尼生物科技有限公司 Refined heparin sodium product and extraction method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张万忠.肝素精制及低分子量肝素的制备.《中国优秀硕士学位论文全文数据库(硕士)工程科技I辑》.2005,(第2期), *
林灿煌,张灿河.正交试验设计优化脱氧剂配方.《福建化工》.2003,(第4期), *

Also Published As

Publication number Publication date
CN103044576A (en) 2013-04-17

Similar Documents

Publication Publication Date Title
CN103044577A (en) Method for reducing dermatan sulfate content in heparin sodium product
CN106381319B (en) Efficient extraction and separation method for grape seed procyanidin oligomers
CN101434608B (en) Preparation of high-purity ellagic acid
WO2011075534A3 (en) Purification of isoprene from renewable resources
MY149879A (en) Process for producing acrylic acid, apparatus for producing acrylic acid, and composition for producing acrylic acid
WO2011132729A1 (en) Method for producing crystalline iron arsenate starting material liquid from smoke and ash
CN103044576B (en) Method for improving stability of heparin sodium
EP1813635A4 (en) Process for production of polyethers and polymers
CN111484539A (en) Novel process method for extracting hesperidin by alkaline alcohol
CN103044578A (en) Efficient method for refining heparin sodium crude products
CN105037473B (en) A kind of method of the purification sterol from tall oil
CN113647623B (en) Method for improving anthocyanin stability
CN1193995C (en) Method of extracting oligo proanthocyanidin of grape seed
CN103102294A (en) Production method carboxymethyl cysteine
CN112940150A (en) Method for preparing heparin calcium from heparin sodium
CN101412710B (en) Omeprazole sodium compound and preparation thereof
CN102924964A (en) Process for extracting and purifying monascus red pigment without citrinin
CN109485558B (en) Purification method of long-chain dibasic acid
CN106927597B (en) Treatment of waste water from isophorone production comprising neutralization, filtration and downstream chemical oxidation process with subsequent reduction
CN102453736A (en) Method for transforming hyperin into quercetin by enzyme reaction
CN108622869B (en) method for purifying wet-process phosphoric acid by solvent extraction method
CN102070686A (en) Method for extracting rutin from pagodatree flower buds by microwave method
CN106748780B (en) A kind of removal methods of injection Synthetic Oil metal residual
CN111732503A (en) Method for extracting malic acid from calcium malate solution
CN1932022A (en) Process of preparing high purity solanesol with potato leaf as material

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 266100 Zhuzhou Road, Laoshan District, Shandong, No. 97, No.

Patentee after: Qingdao Jiulong biological medicine group Co., Ltd.

Address before: 266100 Zhuzhou Road, Laoshan District, Shandong, No. 97, No.

Patentee before: Qingdao Jiulong Bio-Pharmaceutical Co., Ltd.